Abbott Labs (ABT) PT Lowered to $121 at Goldman Sachs

April 9, 2026 5:55 AM

Goldman Sachs analyst David Roman lowered the price target on Abbott Labs (NYSE: ABT) to $121.00 (from $140.00) while maintaining a Conviction Buy rating.

No results found